Roger Nation
Monash University
H-index: 88
Oceania-Australia
Top articles of Roger Nation
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa | Antimicrobial Agents and Chemotherapy | Jessica R Tait Dovile Anderson Roger L Nation Darren J Creek Cornelia B Landersdorfer | 2024/2/20 |
Elucidating effects of single and multiple resistance mechanisms on bacterial response to meropenem by quantitative and systems pharmacology modeling and population genomics | bioRxiv | Dominika T Fuhs Sara Cortés-Lara Jessica R Tait Kate E Rogers Carla López-Causapé | 2024 |
Distinguishing Inducible and Non-Inducible Resistance to Colistin in Pseudomonas aeruginosa by Quantitative and Systems Pharmacology Modeling at Low and Standard Inocula | Journal of Pharmaceutical Sciences | Jürgen B Bulitta Eunjeong Shin Phillip J Bergen Yinzhi Lang Alan Forrest | 2024/1/1 |
Synergistic effects of inhaled aztreonam plus tobramycin on hypermutable cystic fibrosis Pseudomonas aeruginosa isolates in a dynamic biofilm model evaluated by mechanism-based … | International Journal of Antimicrobial Agents | Siobhonne KJ Breen Marina Harper Carla López-Causapé Kate E Rogers Jessica R Tait | 2024/3/30 |
A population pharmacokinetic model of polymyxin B based on prospective clinical data to inform dosing in hospitalized patients | Clinical Microbiology and Infection | Patrick O Hanafin Andrea Kwa Alexandre P Zavascki Ana Maria Sandri Marc H Scheetz | 2023/9/1 |
Evaluation of Empirical Dosing Regimens for Meropenem in Intensive Care Unit Patients Using Population Pharmacokinetic Modeling and Target Attainment Analysis | Antimicrobial agents and chemotherapy | Guohua An C Buddy Creech Nan Wu Roger L Nation Kenan Gu | 2023/1/24 |
Ceftolozane-tazobactam against Pseudomonas aeruginosa cystic fibrosis clinical isolates in the hollow-fiber infection model: challenges imposed by hypermutability and … | Antimicrobial Agents and Chemotherapy | Jessica R Tait Marina Harper Sara Cortés-Lara Kate E Rogers Carla López-Causapé | 2023/8/17 |
Population pharmacokinetics and target attainment analyses to identify a rational empirical dosing strategy for cefepime in critically ill patients | Antimicrobial agents and chemotherapy | Mohammad H Al-Shaer Michael N Neely Jiajun Liu Kartikeya Cherabuddi Veena Venugopalan | 2020/8/20 |
Clinical pharmacological considerations in an early intravenous to oral antibiotic switch: are barriers real or simply perceived? | Cornelia B Landersdorfer Amanda Gwee Roger L Nation | 2023/4/12 | |
Are We Dosing Correctly? Population Pharmacokinetic Modeling of Cefepime, Piperacillin-Tazobactam, and Meropenem in Individuals with Cystic Fibrosis | Journal of the Pediatric Infectious Diseases Society | Stephanie L Rolsma Andrew G Sokolow Guohua An Nick Fishbane William Fissell | 2023/11/1 |
Correction for Antachopoulos et al.,“Population Pharmacokinetics and Outcomes of Critically Ill Pediatric Patients Treated with Intravenous Colistin at Higher than Recommended … | Antimicrobial Agents and Chemotherapy | Charalampos Antachopoulos Anastasia Geladari Cornelia B Landersdorfer Eleni Volakli Stavroula Ilia | 2023/2/16 |
Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: Resistance mechanisms and synergistic … | International Journal of Antimicrobial Agents | Akosua A Agyeman Carla López-Causapé Kate E Rogers Deanna Deveson Lucas Sara Cortés-Lara | 2023/9/1 |
Penicillin G concentrations required for prophylaxis against Group A Streptococcus infection evaluated using a hollow fibre model and mathematical modelling | Journal of Antimicrobial Chemotherapy | Jessica R Tait Timothy C Barnett Kate E Rogers Wee Leng Lee Madhu Page-Sharp | 2022/7/1 |
A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens | Nature communications | Kade D Roberts Yan Zhu Mohammad AK Azad Mei-Ling Han Jiping Wang | 2022/3/25 |
Penetration of Vancomycin into Noninfected Bone in Patients Undergoing Total Joint Arthroplasty Evaluated by a Minimal Physiologically Based Population Pharmacokinetic Modeling … | Molecular Pharmaceutics | Cornelia B Landersdorfer Wee Leng Lee Roger L Nation David CM Kong Kirsty Buising | 2022/12/13 |
Simulated intravenous versus inhaled tobramycin with or without intravenous ceftazidime evaluated against hypermutable Pseudomonas aeruginosa via a dynamic biofilm model and … | Antimicrobial Agents and Chemotherapy | Hajira Bilal Jessica R Tait Yinzhi Lang Jieqiang Zhou Phillip J Bergen | 2022/3/15 |
597. Are We Dosing Correctly? Population Pharmacokinetic Modeling of Cefepime, Piperacillin-Tazobactam, and Meropenem in Individuals with Cystic Fibrosis | Open Forum Infectious Diseases | Stephanie L Rolsma Guohua An Nick Fishbane William Fissell Kenan Gu | 2022/12/1 |
Antimicrobial polymyxin derivative compounds | 2022/1/18 | ||
A Systems-Based Analysis of Mono-and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections | Antimicrobial agents and chemotherapy | Courtney L Luterbach Hongqiang Qiu Patrick O Hanafin Rajnikant Sharma Joseph Piscitelli | 2022/10/18 |
Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against Pseudomonas aeruginosa for the … | Antibiotics | Jessica R Tait Hajira Bilal Kate E Rogers Yinzhi Lang Tae-Hwan Kim | 2022/1/13 |
